Transcription of US/Italian Multicenter Collaboration
{{id}} {{{paragraph}}}
McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2020 Aug 7:S0002-9343(20)30673-2. doi: Epub ahead of print. PMID: 32771461; PMCID: Multicenter CollaborationAcademic Medical CentersPublic HeathIntegrated Health SystemsCommunity PracticeBiotech IndustrySpecialtiesInternal MedicineCritical CareNephrologyCardiologyElectrophysiolog yInfectious DiseasesOphthalmologyEpidemiologyBiostat isticsDay 0 Symptom Onset 7 days 14 days 21 days 30 days Untreated Mortality RiskCoughDifficulty BreathingFeverSore ThroatMalaiseBody AchesNasal StuffinessLoss of tasteAnorexiaNauseaDiarrheaChest Heaviness/PainDyspneaDesaturationSystemi c ThromboembolismOff-Target AntiviralsCorticosteroidsAntiplatelet Drugs/AntithromboticsSARS-CoV-2 Nasal PCR+Oral PCR/Ag+ D-dimer Hs-CRP LymphocytesAmbulatory Phase
GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA. Pathophysiological Basis and Rationale for Ear ly Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2020 Aug 7:S00029343(20)30673- -2. doi: 10.1016/j.amjmed.2020.07.003. Epub ahead of print.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}